Jim Simons's position in TG Therapeutics is currently worth $12 Million. That's 0.02% of their equity portfolio (837th largest holding). The first TG Therapeutics trade was made in Q3 2014. Since then Jim Simons bought shares twelve more times and sold shares on thirteen occasions. The investor's estimated purchase price is $15.6 Million, resulting in a loss of 23%.